http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011116775-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c999fee6428152a996011d506925c2d7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
filingDate 2011-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_916fa8235942acf0ad69dad6f6fcc0b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4299bba30bd3d3a54e83a6a6b6ab778c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a898853b4b6f43af3f58db116819f9df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0577ca4812b36fc7c6a1590ea41cb26b
publicationDate 2011-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2011116775-A
titleOfInvention Pharmaceutical composition for prevention or treatment of nervous system disorders associated with decreased local cerebral blood flow
abstract PROBLEM TO BE SOLVED: To provide a novel pharmaceutical composition comprising a branched chain amino acid for preventing the transition from latent hepatic encephalopathy to overt encephalopathy. The present invention is a pharmaceutical composition effective for preventing transition from latent hepatic encephalopathy to overt encephalopathy, comprising isoleucine, leucine and valine as active ingredients. [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10471034-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10973793-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11602511-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10238617-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11129804-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11571404-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10682325-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10596136-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10660870-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10201513-B2
priorityDate 2004-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106

Total number of triples: 40.